Search

everythinglearnresearchcommunity

for

Search:↓

A new type of sudden, complete female hair loss was found, with most patients fully recovering within 6 months without needing steroid treatment.

Children with alopecia areata often experience more anxiety and depression, linked to neglectful family dynamics.

Alopecia areata involves persistent gene abnormalities and immune activity, even in regrown hair, suggesting a risk of relapse.

Combining CGF and microneedling with betamethasone effectively treats resistant alopecia areata.

The AA-IGA scale reliably measures treatment success in alopecia areata by considering both clinician and patient views.

The combination of PRP and triamcinolone injections improved hair growth in a man with alopecia areata.

Nail changes in alopecia areata are common and may indicate severity and genetic risk.

Aminexil clinical 5 effectively reduces hair loss and is well-tolerated.

People with autism are more likely to develop alopecia areata than those without autism.

Forsythiaside A helps protect cells and liver from damage by reducing oxidative stress and boosting antioxidants.

Anabolic steroid misuse is a major health issue causing severe health problems and requires better awareness and monitoring.

Transepidermal drug delivery effectively treated areata alopecia with minimal side effects.

FAPD is a possible diagnosis for hair loss in patients of color and requires multiple evaluations for accurate diagnosis.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

Traumatic anserine folliculosis is a harmless skin condition in young males that needs correct diagnosis to avoid unnecessary treatments.

Accurate diagnosis and understanding of alopecia areata in children are crucial for proper treatment.

Hair regrowth was seen in 83% of children with alopecia, immune system plays a role in the condition, and various treatments showed effectiveness for hair and nail disorders.

Nonablative radiofrequency therapy improves hair density, thickness, and growth rate.

Alopecia areata causes hair loss and has various treatment options, but responses differ.

Non-ablative radio frequency can potentially increase hair count in men with androgenetic alopecia, but some may be bothered by the smell during treatment.

AA patients with comorbid conditions face more severe hair loss and need specific treatments.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

Alopecia areata often starts before age 20, is more common in women, and may have a genetic link with other autoimmune diseases.

The summit concluded that new treatments like Jak inhibitors show promise for Alopecia Areata and personalized approaches are needed.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Dermoscopy helps diagnose frontal fibrosing alopecia by identifying specific scalp features.

Tofacitinib may help treat severe hair loss, but more research is needed.

Alopecia areata causes hair loss with varied treatment responses and frequent relapses.